{"result": "(\"entity\"<|>PACIENTES<|>PERSON<|>Patients suffering from chronic diseases such as esclerosis múltiple and ictus who require specific dietary management and monitoring.)\n##\n(\"entity\"<|>NUTRICIÓN<|>EVENT<|>Nutritional management is essential for patients with chronic conditions to improve their quality of life and health outcomes.)\n##\n(\"entity\"<|>SUPLEMENTACIÓN<|>EVENT<|>Supplementation refers to the addition of vitamins and nutrients to the diet of patients with deficiencies or specific health needs.)\n##\n(\"relationship\"<|>PACIENTES<|>ESCLEROSIS MÚLTIPLE<|>Patients with esclerosis múltiple require tailored nutritional management to address their specific health needs.<|>8)\n##\n(\"relationship\"<|>PACIENTES<|>ICTUS<|>Patients with ictus need careful monitoring and dietary adjustments to prevent complications.<|>8)\n##\n(\"relationship\"<|>PACIENTES<|>NUTRICIÓN<|>Patients require nutritional management to enhance their health and well-being, especially in chronic conditions.<|>9)\n##\n(\"relationship\"<|>PACIENTES<|>SUPLEMENTACIÓN<|>Patients may need supplementation of vitamins and nutrients to address deficiencies related to their health conditions.<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: amente, las guías\n                     establecen la necesidad de monitorizar el peso de los pacientes en el curso de\n                     la enfermedad, así como el estatus vitamínico valorando los cambios de peso\n                     y la necesidad de suplementar vitamina D, ácido fólico y vitamina B12 (grado\n                     de recomendación B con un consenso del 91%). Así mismo, se recomienda\n                     poner especial atención en vigilar el estatus de los niveles de homocisteína y\n                     vitaminas del grupo B, por su interrelación con el tratamiento con la levodopa\n                     (grado de recomendación GPP con un consenso del 95%). Igualmente, con\n                     un grado B de recomendación se establece la conveniencia de advertir de la\n                     necesidad de ajuste proteico y los tiempos de las ingestas durante la toma\n                     de levodopa para optimizar su absorción y eficacia. Se recomienda también\n                     aumentar el consumo de pre- y probioticos, mejorando así la hidratación para\n                     tratar el estreñimiento tan frecuente en estos pacientes. Por último, recordar\n                     que el tratamiento nutricional en estos pacientes para mejorar su bienestar y\n                     su calidad de vida debe adaptarse a sus requerimientos de forma individuali-\n                     zada (grado de recomendación GPP con un consenso del 100%).\n             •    Esclerosis múltiple (EM)\n                  –  Cribado de DOF. Se debe realizar un cribado al diagnóstico de la enferme-\n                     dad de forma precoz y durante su evolución; especialmente si existe disfun-\n                     ción cerebelosa, sabiendo que a mayor duración de la enfermedad, existe\n                     mayor riesgo de padecerla. El cribado deberá repetirse de forma regular\n                     dependiendo de cada situación clínica. No existe evidencia suficiente para\n                     establecer una recomendación específica sobre qué método de cribado es\n                     el adecuado en este grupo de pacientes (grado de recomendación GPP con\n                     un consenso del 95%). Las guías reiteran la recomendación de hacer criba-\n                     do de disfagia en los pacientes con esclerosis múltiple de forma rutinaria\n                     en el curso de la enfermedad, sin poder establecer el tiempo exacto de su\n                     realización por no existir evidencia científica que permita establecerlo. Se\n                     recuerda de nuevo que los pacientes con disfunción cerebelosa grave y en-\n                     fermedad de larga duración se identifican como pacientes de mayor riesgo\n                     (grado de recomendación GPP con un consenso del 96%). Igualmente, se\n                     establece, con el mismo grado de recomendación, que se deben realizar\n                     pruebas diagnósticas instrumentales, sin poder especificar cuál es la más\n                     idónea, especialmente en aquellos pacientes con síntomas de disfagia o con\n                     enfermedad incapacitante, de larga duración o afectación cerebelosa). Se\n                     recomienda la utilización de alimentación de textura y viscosidad modifi-\n                     cada en sólidos y líquidos respectivamente en pacientes con EM y disfagia\n                     (grado de recomendación GPP con un consenso del 96%). No se establecen\n\n\n\n42\n---\n                                                        2. Métodos de cribado para la disfagia orofaríngea\n\n\n\n          recomendaciones específicas en el manejo de la disfagia de estos pacientes,\n          se deben seguir las mismas recomendaciones que en otros tipos de población\n          con disfagia (grado de recomendación GPP con un consenso del 100%). Se\n          insiste en iniciar tratamiento con nutrición enteral en los casos en los que los\n          pacientes no sean capaces de cubrir sus necesidades por vía oral. Al igual\n          que en otras enfermedades neurológicas, la colocación de gastrostomía\n          percutánea endoscópica podría ser un método de elección para administrar\n          la nutrición enteral (grado de recomendación B con un consenso del 96%).\n    •  Ictus\n       –  Cribado de DOF. Debe realizarse de la forma más precoz posible y antes\n          de iniciar la ingesta oral (grado de recomendación B). Se hará necesaria una\n          valoración instrumental de la DOF cuando el cribado sea positivo o existan\n          síntomas compatibles lo más precozmente posible (grado de recomenda-\n          ción B con un consenso del 100%).\n       –  Tratamiento de la DOF. La modificación de la viscosidad de los líquidos con\n          espesantes y las dietas de textura modificada, pueden reducir la incidencia\n          de neumonía aspirativa. Tenemos aún insuficientes datos para afirmar que\n          estas modificaciones influyan en la mortalidad de estos pacientes. Estas\n          modificaciones se harán en base a una valoración de la deglución que in-\n          cluya un protocolo con valoración clínica e instumental por profesionales\n          con formación y experiencia en DOF. Se recomienda repetir la evaluación en\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ESCLEROSIS MÚLTIPLE<|>EVENT<|>Esclerosis múltiple (EM) is a chronic disease affecting the central nervous system, requiring regular screening and management of symptoms such as dysphagia and cerebellar dysfunction.)\n##\n(\"entity\"<|>ICTUS<|>EVENT<|>Ictus refers to a medical condition that necessitates early screening and treatment to prevent complications such as aspiration pneumonia.)\n##\n(\"entity\"<|>LEVODOPA<|>EVENT<|>Levodopa is a medication used in the treatment of Parkinson's disease, requiring specific dietary adjustments for optimal absorption.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>Nutritional support provided through enteral feeding for patients unable to meet their dietary needs orally.)\n##\n(\"entity\"<|>DOF<|>EVENT<|>Dysphagia oropharyngeal (DOF) is a condition that requires screening and management in patients with neurological disorders.)\n##\n(\"entity\"<|>VITAMINA D<|>EVENT<|>Vitamin D is a nutrient that may need to be supplemented in patients with chronic diseases to maintain health.)\n##\n(\"entity\"<|>ÁCIDO FÓLICO<|>EVENT<|>Folic acid is a vitamin that may be supplemented in patients with specific health conditions.)\n##\n(\"entity\"<|>VITAMINA B12<|>EVENT<|>Vitamin B12 is a nutrient that may require supplementation in patients with certain medical conditions.)\n##\n(\"entity\"<|>HOMOCISTEÍNA<|>EVENT<|>Homocysteine is an amino acid that needs to be monitored in patients undergoing treatment with levodopa.)\n##\n(\"relationship\"<|>ESCLEROSIS MÚLTIPLE<|>DOF<|>Patients with esclerosis múltiple are at risk for dysphagia, necessitating regular screening for this condition.<|>8)\n##\n(\"relationship\"<|>ICTUS<|>DOF<|>Ictus patients require early screening for dysphagia to prevent complications.<|>8)\n##\n(\"relationship\"<|>LEVODOPA<|>VITAMINA D<|>Levodopa treatment may require vitamin D supplementation to address deficiencies in patients.<|>5)\n##\n(\"relationship\"<|>LEVODOPA<|>ÁCIDO FÓLICO<|>Levodopa treatment may necessitate folic acid supplementation for optimal patient health.<|>5)\n##\n(\"relationship\"<|>LEVODOPA<|>VITAMINA B12<|>Levodopa treatment may require vitamin B12 supplementation to support patient health.<|>5)\n##\n(\"relationship\"<|>LEVODOPA<|>HOMOCISTEÍNA<|>Monitoring homocysteine levels is important for patients undergoing treatment with levodopa.<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>ICTUS<|>Nutritional support through enteral feeding may be necessary for ictus patients who cannot meet their dietary needs orally.<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>ESCLEROSIS MÚLTIPLE<|>Enteral nutrition may be required for patients with esclerosis múltiple who are unable to eat orally.<|>6)\n<|COMPLETE|>"}]}